Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: Correlation with disease activity
N. Pucci et al., Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: Correlation with disease activity, J ALLERG CL, 105(2), 2000, pp. 353-357
Background: Eosinophil cationic protein (ECP) and eosinophil protein X (EPX
) or eosinophil-derived neurotoxin (EDN) are released by eosinophil granulo
cytes in allergic diseases. Serum ECP (s-ECP) levels have been correlated w
ith disease activity in atopic dermatitis (AD) in adults and young patients
, and high urinary EPX (u-EPX) levels in asthmatic patients seem to reflect
active disease. A relationship between AD severity and u-EPX concentration
in young children has not been previously studied.
Objective: This study was performed to evaluate whether the severity of AD
in infants and young children was correlated with s-ECP and u-EPX levels.
Methods: Fifty-four infants and children (mean age, 17.7 months; range, 4-4
8 months) with AD and without other allergic conditions were evaluated. The
severity of AD was measured by using the SCORAD index. S-ECP, serum total
IgE, serum-specific IgE for common allergens, and peripheral blood eosinoph
il counts (PBECs) were determined. In forty-two children u-EPX was also mea
sured. Seven age-matched control patients underwent the same determinations
.
Results: S-ECP and u-EPX were significantly higher in children with AD than
in control children (mean, 23.9 vs 3.5 mu g/dL [P < .001] and 57.7 vs 6.0
mu g/mmol creatinine [P < .001]). A significant correlation was found betwe
en SCORAD and s-ECP (P = .002), u-EPX (P = .01), and PBECs (P = .01) and be
tween symptom index and uEPX (P = .0004), PBECs were strongly correlated to
s-ECP and u-EPX (P < .0001). However, 5 patients with moderate and severe
AD (11.9%) showed low levels of s-ECP, u-EPX, and PBECs.
Conclusion: S-ECP and u-EPX were useful markers of AD activity in infants a
nd young children. When taken together, the two determinations could give m
ore information about the clinical course of the illness. Some patients see
med to have clinical exacerbations without an involvement of eosinophils an
d their products.